🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital

Recruitingn/aAges 18 Years - anyAllSohag University
NCT06953921 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. assess the impact of albumin level on clinical course and outcomes of HE.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients aged \>18 years. * Confirmed chronic liver disease (by imaging , * liver function tests , and clinical history). * Diagnosed with hepatic encephalopathy based on clinical criteria. * Patients able to provide informed consent. Exclusion Criteria: * Patients age less than 18 years old * Acute liver failure. * Chronic renal failure on dialysis. * Pregnant women. * Patients with active malignancy.
💊

What it tests

  • Not listed
📍

Where

1 site
Sohag university hospital
Sohag, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy